Brussels startup directory
Explore startups, investors, and ecosystem operators in Brussels, Belgium.
Showing 21–31 of 31Brussels · Belgium
Other cities in Belgium
Brussels · Belgium results
FOSDEM 2026
Free and open source software developers' conference, covering a wide range of topics and technologies. A major community-driven event for open source enthusiasts and professionals in Brussels.
Hans Roth
Hans Roth is Senior Vice President and General Manager for EMEA at Red Hat, the world's leading provider of enterprise open source software solutions and an IBM subsidiary. In this role he oversees Red Hat's business across Europe, the Middle East, and Africa, driving enterprise adoption of open source technologies including Red Hat Enterprise Linux, OpenShift Kubernetes platform, and Ansible automation. He is a senior technology industry executive with significant influence in the European enterprise software and cloud infrastructure market.
Horizon Europe Road Mobility Brokerage Event 2026
Matchmaking event for Horizon Europe mobility calls. Price: free with registration. Focused on 1:1 meetings to build consortia for non-dilutive EU funding.
Keyrock
Keyrock is a Brussels-based digital-asset market-making and trading firm offering market making, OTC and options trading, onchain liquidity provisioning, and asset-management strategies for crypto markets. It also provides ecosystem-development and validator services, publishes crypto-market research, and recently raised Series C funding from SC Ventures.
Masters of Digital 2026
High-level forum in Brussels on EU digital policy, AI competitiveness, and innovation-friendly regulation, bringing together MEPs, commissioners, and tech industry leaders. Features policy debates and networking with European regulators. Essential for startups navigating EU regulatory frameworks and seeking influence on digital policy outcomes.
Masters of Digital 2027
Masters of Digital 2027 runs 3-4 February in Brussels, organised by DIGITALEUROPE. The event brings together EU leadership, national governments, industry CEOs, founders and investors on one stage to discuss digital and defence policy, with the 2027 agenda to be published in stages.
Niklas Blomberg
Niklas Blomberg is Executive Director of the Innovative Health Initiative (IHI), a major public-private partnership joint undertaking established by the European Union and EFPIA with approximately €2 billion in funding for health research and innovation. He oversees one of Europe's most significant health R&D programmes, bridging academia, industry, regulators, and patient organisations. He is a key figure in European health innovation policy and ecosystem building.
OpenForum Europe
Advocacy organisation promoting open source, open standards, and open markets in Europe, particularly concerning public policy and digital infrastructure. Organises the EU Open Source Policy Summit.
RenovSmart
Belgian AI marketplace that matches homeowners with verified renovation and construction companies across Belgium. Its AI engine analyses project requirements, cross-references contractor track records, and surfaces ranked shortlists within minutes. All partner companies undergo tax and solvency verification. Invited to VivaTech 2026.
Siegfried Jaeken
Siegfried Jaeken is Managing Director for Data & AI at Accenture, one of the world's leading professional services and consulting firms with annual revenues exceeding $60 billion. In this senior leadership role he oversees Accenture's data strategy and artificial intelligence practice for European markets, guiding enterprise clients through AI-driven business transformations at scale.
Sofina
Sofina is a Brussels-based investment holding company listed on Euronext Brussels that invests in growth-stage technology companies, consumer brands, and education platforms worldwide. With a heritage dating back to 1898, Sofina manages over $10 billion in assets and has backed major European and global companies including ByteDance, Delivery Hero, and Flixbus. The firm focuses on long-term holdings and typically invests from Series B through pre-IPO, bringing patient capital and a multi-generational investment perspective.